Resources with keywords: risk factors



COVID-19 Personal Plan (Document)
CDC

Tools, information, and action steps to share with your family, friends, and healthcare provider

SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages (Website, Publication)
Science: Translational Medicine
22 September 2022

Martínez-Colón GJ, Ratnasiri K, et al.
Authors state that the data suggest that SARS-CoV-2 infection of adipose tissue could contribute to COVID-19 severity through replication of virus within adipocytes and through induction of local and systemic inflammation driven by infection of adipose tissue-resident macrophages.

Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 (NEW 5/6, Website, Regulatory)
CDC/Health Alert Network (HAN)
25 April 2022
Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India (NEW 2/3, Website, Publication)
JAMA Ophthalmology
1 January 2022

Choksi T, et al.

An outbreak of COVID-19-associated rhino-orbitocerebral mucormycosis (CAM) has occurred in many parts of the world. Although the clinical profile and risk factors for CAM have been studied, cumulative mortality and its risk factors have not.

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study (NEW 2/3, Website, Publication)
The Lancet: Infectious Diseases
1 January 2022

Antonelli M, et al.

This study aimed to identify risk factors for post-vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness.

Go to Top